Acute myeloid leukemia (AML) is a disease of older adults, with a median age at diagnosis over 65 years. Studies from real-world practice1 and experimental clinical trials2, 3, 4 have documented that age and frailty are prime predictors of outcome in AML.

Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making.

TOSI, PATRIZIA;ZINZANI, PIER LUIGI;TURA, SANTE
2013

Abstract

Acute myeloid leukemia (AML) is a disease of older adults, with a median age at diagnosis over 65 years. Studies from real-world practice1 and experimental clinical trials2, 3, 4 have documented that age and frailty are prime predictors of outcome in AML.
Ferrara F;Barosi G;Venditti A;Angelucci E;Gobbi M;Pane F;Tosi P;Zinzani P;Tura S
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11585/396411
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 23
  • Scopus 48
  • ???jsp.display-item.citation.isi??? 48
social impact